Fact CheckerSign in

NCT06920602Completed

AI Chatbot for Migraine Management in Hong Kong Women

Development and Evaluation of an AI-empowered Voice-interactive Chatbot for Migraine Management Among Hong Kong Women: a Randomized Crossover Trial

Source: ClinicalTrials.gov · Last updated 15 Dec 2025

Brief summary (registry, in English)

The goal of this randomized crossover trial is to examine whether the AI-empowered chatbot will effectively collect comprehensive migraine feature data and demonstrate higher compliance, accuracy, utilization, acceptability, feasibility, and validity in migraine feature tracking compared to traditional paper-based migraine diaries among Hong Kong women with migraine. Participants will use different tools (AI-empowered voice-interactive chatbot or paper migraine diary) for migraine tracking. Participants will be randomly allocated to one of two intervention sequences: (1) AI-empowered voice-interactive chatbot followed by paper migraine diary, or (2) paper migraine diary followed by AI-empowered voice-interactive chatbot. The study will consist of two intervention periods, each lasting one month, with a 1:1 allocation ratio.

Status (registry)
Completed
Study type
Interventional
Enrollment
49 (actual)
First submitted
10 Mar 2025
Start date
Jul 2025
Primary completion date
Nov 2025
Lead sponsor
The Hong Kong Polytechnic University
Diseases
Migraine
NCT number
NCT06920602

What you commit to

  • Study type: Interventional
  • Participants enrolled: 49
  • From Jul 2025 to the primary completion date, Nov 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Individuals with severe cognitive impairments or communication difficulties
  • Those unable to use a smartphone or the chatbot due to physical or mental limitations
  • Using another alternative electronic migraine diary during recruitment or in the past 12 weeks

Who the study is looking for

  • Women aged 18 years or older
  • Meet diagnostic criteria for migraine according to ICHD-3
  • Experiencing at least 2 headache days per month
  • Living in Hong Kong
  • Fluent in Cantonese
  • Owning a smartphone with internet access
  • Willing to provide informed consent

Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
The Hong Kong Polytechnic University
Coordinator of this site? Confirm its status
Hong KongHong Kong SAR ChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.